COVID - 19 vaccines ? - Successful? with 200 mutations

2 Likes

LikeAnswersShare
This is a major challenge in the present scenario to develop effective vaccine for COVID 19 because of frequent genetic mutations approximately 200 . Eventhough major pharmaceutical companies are trying to come out with vaccine for COVID 19. In my post briefly i explained four vaccines were expecting from various institutes, University of Oxford, serum institute of India ,Moderna RNA vaccine, Sinovac biotec and pfizer vaccine,etc. Main concern is how to stop mutation of COVID-19 virus. Our aim is to focus on the parts of virus that are less likely to mutate , so that we have better chance of developing drugs to control the virus. Whole world is effected by COVID-19. Whether upcoming COVID 19 vaccines are successful or not , we should wait and watch. Vaccine for virus is always a tough job because of instability and mutations of viruses. Researchers are putting their full efforts to come up with effective vaccine for COVID 19 as this became pandemic. Hope always gives us energy to fight this pandemic .
Wonderful eloborate Evidence Based Medicine Dr Devi as usual. Thanks again
0

View 5 other replies

Vaccine, development of herd immunity, Would be a difficult task in current situation. Rather, we should learn to live with this virus. Mutation are bound to occur from viral survival point of view. Perhaps active immunity would work over the period. We indians are living with TB, various seasonal flu,and other respiratory pathogens, where mortality is high. Without taking vaccine for each strain of bacteria, viruses, our immune system has learned developing natural immunity. So time is the best vaccine for Harmony of mind and body.
Valuable opinion
0
Yes very relevent question Every body talking about vaccination It is also true we in india neither vaccinate or pt is willing to get vaccinised Natural immunity will develop over period of time as we saw in seine flu epidemic and other infections HERDIMMUNITY will come into play yes at a great human cost
Absolutely sir. And would be very difficult to cover vaccination in such a huge population and it's accountability.
0

View 2 other replies

By analysing virus genomes from over 7,500 people infected with Covid-19, a UCL-led research team has characterised patterns of diversity of SARS-CoV-2 virus genome, offering clues to direct drugs and vaccine targets.
Valuable opinion
0
Multivalent may be the solution

Cases that would interest you